Brief: Relief Therapeutics Signs Definitive Agreement To Acquire Novel Dosage Form For Treatment Of PKU

MindMaze Therapeutics Holding SA

13/07/2022 06:09

July 13 (Reuters) - RELIEF THERAPEUTICS HOLDING SA  RLFB.S :
    * RELIEF SIGNS A DEFINITIVE AGREEMENT TO ACQUIRE A NOVEL
DOSAGE
FORM OF AN ALREADY APPROVED PRESCRIPTION DRUG FOR THE TREATMENT
OF PKU
    * FINANCIAL TERMS OF AGREEMENT WERE NOT DISCLOSED

Source text for Eikon:  ID:nEQ7sfbzDa 
Further company coverage:  RLFB.S 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))